CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 49 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,440,000 | -11.2% | 50,000 | -37.5% | 1.27% | -28.0% |
| Q3 2020 | $1,621,000 | -17.0% | 80,000 | +23.1% | 1.76% | -20.1% |
| Q2 2020 | $1,953,000 | -40.8% | 65,000 | -38.1% | 2.21% | -50.3% |
| Q1 2020 | $3,300,000 | -36.3% | 105,000 | -4.5% | 4.44% | -19.6% |
| Q4 2019 | $5,182,000 | +401.2% | 110,000 | -31.2% | 5.52% | +328.3% |
| Q3 2019 | $1,034,000 | -29.9% | 160,000 | +33.3% | 1.29% | -19.1% |
| Q2 2019 | $1,474,000 | – | 120,000 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |